|
Z-Valaciclovir
|
Z-伐昔洛韋
|
124832-31-1
|
|
3-(hexyloxy)-4-(pyridin-3-yl)-1,2,5-thiadiazole
|
3-(4-已氧基-1,2,5 -噻二唑-3-基)吡啶
|
131987-69-4
|
|
2-Chloro-N-(4-methylphenyl)propanamide
|
2-氯-N-(4-甲基苯基)丙酰胺
|
147372-41-6
|
|
Doltenolil control
|
多替諾雷對照品
|
1285572-51-1
|
|
1-Methoxy-3-(trimethylsilyloxy)-1,3-butadiene
|
1-甲氧基-3-三甲基硅氧基-1,3-丁二烯
|
59414-23-2
|
|
Flurbiprofen Impurity d(4-ACB)
|
氟比洛芬雜質(zhì)d(4-ACB)
|
477860-13-2
|
|
3-hydroxy-4H-pyran-4-one
|
3-羥基-4氫-吡喃-4-酮
|
496-63-9
|
|
2-(Propamino)-N-(o-toluene)acetamide
|
2-(丙氨基)-N-(鄰甲苯基)乙酰胺
|
145133-92-2
|
|
FTD-17 epimer
|
FTD-17位差向異構(gòu)體
|
140375-21-9
|
|
Dotinurad Impurity 2
|
多替諾雷雜質(zhì)2
|
137-07-5
|
|
Lornoxicam impurity SM3-2
|
氯諾昔康雜質(zhì)SM3-2
|
6482-26-4
|
|
1,1-Dimethylethyl 2,4,6-trideoxy-3,5-O-(1-methylethylidene)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]-D-erythroheconate
|
1,1-二甲基乙基 2,4,6-三脫氧基-3,5-O-(1-甲基亞乙基)-6-[(5-甲基-1,3,4-噻二唑-2-基)磺酰基]-D-赤己糖酸鹽
|
1326302-97-9
|
|
Cefazolin Ep Impuirty L
|
頭孢唑林 EP 雜質(zhì) L
|
|
|
Chlorphenamine EP Impurity D
|
氯苯那敏 EP雜質(zhì)D
|
65676-21-3
|
|
|
[（1R，5S，6S）-6-(氨甲基）-3-乙基雙環(huán)[3.2.0]庚-3-烯-6基]乙酸叔丁酯扁桃酸鹽
|
|
|
E-2-3
|
|
|
|
E-1-4
|
E-1-4
|
83121-15-7
|
|
|
硫酸艾莎康唑雜質(zhì)C
|
2962831-01-0
|
|
Fluthioxetine hydrobromide impurity 10
|
氫溴酸氟硫西汀雜質(zhì)10
|
|
|
2,6-diaminophenol
|
2,6-二氨基苯酚
|
22440-82-0
|
|
Stiripentol Impurity 4
|
司替戊醇雜質(zhì)4
|
106175-03-5
|
|
Cefazolin Impurity N
|
頭孢唑林鈉雜質(zhì) N
|
2384108-14-7
|
|
Sulfuric acid, bis(2-Methylpropyl) ester
|
硫酸雙（2-甲基丙基）酯
|
23304-40-7
|
|
YD-SM201
|
|
7463-53-8
|
|
Cefazolin USP Impurity A
|
頭孢唑林USP雜質(zhì)A
|
21732-17-2
|
|
Cefazolin Impurity B
|
頭孢唑林雜質(zhì)B
|
1675245-47-2
|
|
Cefazolin Impurity H
|
頭孢唑林雜質(zhì)H
|
56842-77-4
|
|
Cefazolin Impurity L
|
頭孢唑林雜質(zhì)L
|
1675244-99-1
|
|
Impurity 14
|
雜質(zhì)14
|
1252018-10-2
|
|
TL-Z2
|
|
69240-90-0
|
|
Demethylparool
|
去甲基帕羅醇
|
220548-73-2
|
|
N-Nitroso Paroxetine
|
N-硝基帕羅西汀
|
2361294-43-9
|
|
E-2-1
|
|
118452-04-3
|
|
Mirabelon intermediates 4
|
米拉貝隆中間體4
|
223673-36-7
|
|
Escitalopram oxalate impurity 05
|
草酸艾司西酞普蘭雜質(zhì)05
|
762266-07-9
|
|
Escitalopram oxalate impurity 03
|
草酸艾司西酞普蘭雜質(zhì)03
|
1433278-32-0
|
|
AZD9291 chloropropylamide
|
AZD9291氯丙酰胺
|
1421373-36-5
|
|
1C in benzethazine impurities
|
芐絲肼雜質(zhì)中1C
|
5625-41-2
|
|
BBXS-B
|
|
14737-89-4
|
|
Valsartan Impurity INT1-C (Valsartan Impurity E)
|
纈沙坦雜質(zhì)INT1-C（纈沙坦雜質(zhì)E）
|
443093-86-5
|
|
VAL impurity INT1-B
|
VAL雜質(zhì)INT1-B
|
1189547-11-2
|
|
Finerenone P1-5
|
非奈利酮P1-5
|
|
|
Ruxolitinib INT3-A
|
蘆可替尼INT3-A
|
|
|
Finerenone RG
|
非奈利酮RG
|
|
|
Roxadustat impurity IV-7 control
|
羅沙司他雜質(zhì)IV-7對照品
|
|
|
Vonoprazan Impurity 102
|
沃諾拉贊雜質(zhì)102
|
403-29-2
|
|
Tofacitinib Impurity 22 TF103-K
|
托法替尼雜質(zhì)22 TF103-K
|
2227199-28-0
|
|
Anthenioxysulfuryl chloride
|
茴二氧基硫酰氯
|
105764-39-4
|
|
3-Azetidinecarboxylic acid, 1-[[4-[(1Z)-1-[[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]imino]ethyl]-2-ethylphenyl]methyl]-
|
|
2768181-14-0
|
|
Amoxetine HA1405-Impurity 1
|
阿姆西汀HA1405-雜質(zhì)1
|
|
|
6-(6-Aminohexanamido)hexanoic acid
|
6-[(6-氨基-1-氧代己基)氨基]-己酸
|
2014-58-6
|
|
Fenofibrate impurity J
|
非諾貝特雜質(zhì)J
|
388632-17-5
|
|
Triazine ring impurities
|
三嗪環(huán)雜質(zhì)
|
68984-32-7
|
|
Impurity H
|
雜質(zhì)h
|
125995-03-1
|
|
Escitalopram oxalate impurity 04
|
草酸艾司西酞普蘭雜質(zhì)04
|
260371-16-2
|
|
MD102-Z2
|
|
35139-68-5
|
|
Finerenone P5-2
|
非奈利酮P5-2
|
65582-57-2
|
|
hydride
|
氫化物
|
76820-35-4
|
|
|
硫酸艾莎康唑雜質(zhì)A
|
2732924-99-9
|
|
|
（1R，5S，6S）-3-乙基螺環(huán)[雙環(huán)[3.2.0]庚-3-烯-6，3’吡咯烷]-5’-酮
|
3042853-06-2
|
|
E-2-5
|
E-2-5
|
|
|
GLT-Q
|
|
|
|
N-(o-tolyl)propionamide
|
N-(鄰甲苯基)丙酰胺
|
19343-15-8
|
|
Norepinephrine impurity D hydrochloride
|
去甲腎上腺素雜質(zhì)D 鹽酸鹽
|
66403-32-5
|
|
2-Hydroxy-2-(pyridin-3-yl)acetic acid
|
2-羥基-2-(吡啶-3-基)乙酸
|
49769-60-0
|
|
Atorvastatin Related Compound C
|
阿托伐他汀鈣雜質(zhì)C
|
693793-53-2
|
|
SHJJBBTS-D
|
SHJJBBTS-C
|
918641-99-3
|
|
Fenofibrate impurity Ⅱ-5
|
非諾貝特雜質(zhì)Ⅱ-5
|
31702-79-1
|
|
Escitalopram oxalate impurity 01
|
草酸艾司西酞普蘭雜質(zhì)01
|
762266-09-1
|
|
1-(2-Chlorophenyl)-2-(1-tetrazolyl)ethanone
|
1-(2-氯苯基)-2-(1-四唑基)乙酮
|
1259059-68-1
|
|
(R)-N-Benzyl-2-(3-Benzylureido)-3-Methoxypropanamide
|
（R） -N-芐基-2-（3-芐基脲基）-3-甲氧基丙酰胺
|
2295925-90-3
|
|
Finerenone RJ
|
非奈利酮RJ
|
3046142-41-7
|
|
Azilsartan Impurity E
|
美阿沙坦鉀雜質(zhì)E
|
1565796-93-1
|
|
Cefazolin Impurity N
|
頭孢唑林雜質(zhì)N
|
|
|
LeterMovir Impurity INT3-F
|
萊特莫韋雜質(zhì)INT3-F
|
2864441-31-4
|
|
Linagliptin impurity E trifluoroacetate
|
利格列汀雜質(zhì)E 三氟乙酸鹽
|
|
|
Bempedoic acid Impurity 17
|
貝派地酸雜質(zhì)17
|
2570179-40-5
|
|
Urapidil Impurity (w-4-2)
|
烏拉地爾雜質(zhì)(w-4-2)
|
793672-13-6
|
|
Dotinurad Impurity 3
|
多替諾雷雜質(zhì)3
|
29568-76-1
|
|
3-(1,2,5-thiosadiazepine-3-yl)pyridine
|
3-(1,2,5-硫雜二氮雜環(huán)戊熳-3-基)吡啶
|
131987-88-7
|
|
6-[5-Amino-3-(4-phenoxy-phenyl)-4,5-dihydro-1H-pyrazole-4-yl]-3-(4-phenoxy-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
6-[5-氨基-3-（4-苯氧基-苯基）-4,5-二氫-1H-吡唑-4-基]-3-（4-苯氧基-苯基）-1H-吡唑并[3,4-d]嘧啶-4-胺
|
|
|
Fenofibrate impurity H
|
非諾貝特雜質(zhì)H
|
2991460-92-3
|
|
Atorvastatin Related Compound D
|
阿托伐他汀鈣雜質(zhì)D
|
148146-51-4
|
|
2-Hydroxy-3',4'-dihydroxyacetophenone
|
3,4-二羥基苯酰甲醇
|
29477-54-1
|
|
Cefazolin Impurity J
|
頭孢唑林雜質(zhì)J
|
32510-61-5
|
|
Finerenone RE
|
非奈利酮RE
|
3046141-72-1
|
|
1,2-Bis(4-phenylbutyrate)-3-hydroxypropanediester
|
1,2-雙（ 4-苯丁酸） -3-羥基丙二酯
|
1443417-10-4
|
|
4-amino-1,3-dihydro-2H-benzo[d]imidazole-2-thione
|
4-氨基-1，3-二氫-2H-苯并[d]咪唑-2-硫酮
|
19462-97-6
|
|
E-2-2
|
|
|
|
Impurity BLPN-Z2
|
雜質(zhì) BLPN-Z2
|
|
|
Ruxolitinib SM2-G
|
蘆可替尼SM2-G
|
|
|
Finerenone P1-4-Z
|
非奈利酮P1-4-Z
|
|
|
Vitamin A palmitate oxidized Impurity
|
維生素A棕櫚酸酯氧化雜質(zhì)
|
3012-64-4
|
|
|
[（1S，5R，6S）-6-(氨甲基）-3-乙基雙環(huán)[3.2.0]庚-2-烯-6基]乙酸
|
1234045-56-7
|
|
Cefazolin Impurity M
|
頭孢唑林雜質(zhì)M
|
|
|
Propyl benzylcarbamate
|
芐基氨基甲酸丙酯
|
|
|
SHJJBBTS-D
|
|
71433-06-2
|
|
|
5-[4-(己基氧基)-1,2,5-硫雜二氮雜環(huán)戊熳-3-基]-3-羥基-1-甲基吡啶-1-正離子
|
2414049-88-8
|
|
|
[（1R，3E，5R，6S）-6-(氨甲基）-3-亞乙基雙環(huán)[3.2.0]庚-3-烯-6基]乙酸
|
1644251-71-7
|
|
|
美阿沙坦鉀雜質(zhì)
|
3031851-96-1
|